Skip to main content
. 2021 Aug 5;12:20420986211038436. doi: 10.1177/20420986211038436

Table 1.

Examples of WHO Alerts of falsified products.

WHO Ref. Product Falsification issue Region
Product Alert
No. 2/202138
COVID-19 ‘BNT162b2’ vaccine Falsified glass vials and label (batch number and expiry dates) Mexico
Product Alert
No. 7/202039
HARVONI (ledipasvir/sofosbuvir) Misrepresentation of its identity, composition and source WHO regions of the Americas and Europe
Product Alert
No. 5/202040
Defitelio (defibrotide) Falsified batches not containing the expected active ingredient, contaminated with mould (Cladosporium sp. and Aspergillus niger) Argentina, Australia, Latvia, Malaysia and Saudi Arabia
Product Alert
No. 4/202041
Chloroquine/Hydroxychloroquine Misrepresentation of its identity, composition and source WHO regions of Africa
Product Alert
No. 3/202042
COVID-19 diagnostics Falsified in vitro diagnostics and laboratory reagents Not reported
Product Alert
No. 11 /201943
Amoxicillin and Clavulanic Acid Falsified batches and labelling and packaging inconsistencies Haiti
Product Alert
No. 8 /201944
Rabies Vaccines (Verorab, Speeda and Rabipur) and Anti-Rabies Serum (Equirab) Falsified label (batch number and expiry dates) Philippines
Product Alert
No. 7/201945
Meglumine antimoniate ampoules (Gulucatime/Glucantime) Falsified label and products produced not according to the GMP requirements Iran and Pakistan
Product Alert
No. 6 /201946
Hydrochlorothiazide Found to contain glibenclamide instead of hydrochlorothiazide Cameroon

GMP, good manufacturing practice; WHO: World Health Organisation.